Contrasting Tivic Health Systems (NASDAQ:TIVC) & Schrodinger (NASDAQ:SDGR)

Tivic Health Systems (NASDAQ:TIVC) and Schrodinger (NASDAQ:SDGR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability and risk.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Tivic Health Systems and Schrodinger, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tivic Health Systems	1	0	0	0	1.00
Schrodinger	1	3	4	0	2.38

Schrodinger has a consensus price target of $26.29, indicating a potential upside of 47.84%. Given Schrodinger’s stronger consensus rating and higher possible upside, analysts plainly believe Schrodinger is more favorable than Tivic Health Systems.

Insider and Institutional Ownership

4.3% of Tivic Health Systems shares are owned by institutional investors. Comparatively, 79.1% of Schrodinger shares are owned by institutional investors. 0.5% of Tivic Health Systems shares are owned by insiders. Comparatively, 21.0% of Schrodinger shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Tivic Health Systems and Schrodinger’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tivic Health Systems	-148.49%	-22.69%	-18.94%
Schrodinger	-68.49%	-48.24%	-24.21%

Volatility and Risk

Tivic Health Systems has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500. Comparatively, Schrodinger has a beta of 1.77, indicating that its share price is 77% more volatile than the S&P 500.

Earnings and Valuation

This table compares Tivic Health Systems and Schrodinger”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tivic Health Systems	$462,000.00	5.23	-$9.34 million	($8.62)	-0.26
Schrodinger	$207.54 million	6.31	-$187.12 million	($2.41)	-7.38

Tivic Health Systems has higher earnings, but lower revenue than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Tivic Health Systems, indicating that it is currently the more affordable of the two stocks.

Summary

Schrodinger beats Tivic Health Systems on 9 of the 14 factors compared between the two stocks.

About Tivic Health Systems

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

About Schrodinger

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.